TAB2 scaffolds TAK1 and NLK in repressing canonical Wnt signaling

Area of Science:

• Cellular signaling pathways
• Molecular biology
• Signal transduction

Background:

• The TAK1-NLK cascade is a mitogen-activated protein kinase-related pathway.
• This pathway inhibits canonical Wnt/beta-catenin signaling by regulating LEF1/TCF transcription factors.
• TAB2 (TAK1-binding protein 2) is known to be involved in TAK1 regulation.

Purpose of the Study:

• To investigate the role of TAB2 in the TAK1-NLK signaling pathway.
• To elucidate the mechanism by which TAB2 interacts with TAK1 and NLK.
• To determine the function of the TAK1-TAB2-NLK complex in Wnt signaling regulation.

Main Methods:

• Small interfering RNA (siRNA) for TAB2 knockdown.
• Co-immunoprecipitation assays to detect protein interactions.
• Site-directed mutagenesis to create TAB2 mutants (TAB2-DeltaM).
• Analysis of LEF1 polyubiquitylation and Wnt signaling activity.

Main Results:

• TAB2 directly interacts with NLK and acts as a scaffold protein, facilitating TAK1-NLK interaction.
• Knockdown of TAB2 disrupts the TAK1-NLK complex formation.
• The intermediate region (residues 292-417) of TAB2 is essential for NLK binding and scaffolding function.
• TAB2 mediates TAK1-dependent activation of NLK and LEF1 polyubiquitylation, inhibiting Wnt signaling.
• Wnt3a stimulation enhances TAB2-NLK interaction and TAK1.TAB2.NLK complex formation.

Conclusions:

• TAB2 is a crucial scaffold protein in the TAK1-NLK pathway, essential for its inhibitory function on Wnt/beta-catenin signaling.
• The TAK1-TAB2-NLK complex acts as a negative feedback mechanism to regulate canonical Wnt signaling.
• Targeting the TAB2-mediated scaffolding could offer new therapeutic strategies for Wnt-related diseases.